Search patents:
Romidepsine et 5-azacitidine pour l'utilisation dans le traitement ...
Filed: January 1st, 1970 [Granted]
Patent Number: WO2013043967A1
Les méthodes comprennent l'administration d'un inhibiteur d'HDAC, la romidepsine, et d'un agent de déméthylation de l'ADN, la 5-azacitidine, également ...
Procédé pour la synthèse d'azacitidine et de décitabine
Filed: January 1st, 1970 [Granted]
Patent Number: EP2371825B1
Procédé pour la synthèse d'azacitidine et de décitabine ... Procédé selon la revendication 3, caractérisé en ce que 2,2 à 2,5 moles de N ...
Biomarqueurs de méthylation génique et leurs procédés d'utilisation
Filed: January 1st, 1970 [Granted]
Patent Number: WO2013022872A1
Des méthodes pour prédire le taux de survie global de certaines classes de ... et des méthodes pour sélectionner des patients atteints de SMD ou de ... Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine.
Desmoglein 2 (dsg2) binding proteins and uses therefor
Filed: January 1st, 1970 [Granted]
Patent Number: WO2014052322A1
254: 539 (1991), Barahmand-Pour et al, Curr. Top. .... including ALIMTA® ( pemetrexed disodium, LY231514, MTA), 5-azacitidine, XELODA®.
Nouvelle composition pour le controle de la croissance tumorale
Filed: January 1st, 1970 [Granted]
Patent Number: WO2007114697A1
5, no. 3, June 2005 (2005-06), pages 277-291, XP009085930 ISSN: .... Celgene Corporation, Romidepsine et 5-azacitidine pour l'utilisation ...
Human monocyte-macrophage-CSF preparations
Human monocyte-macrophage-CSF preparations
Filed: January 1st, 1970 [Granted]
Patent Number: US5288487
... and granulocyte numbers after bone marrow transplantation (cf: T. Masaoka et al, Bone ... MDS are categorized into 5 types depending upon patients' conditions or .... The resultant fraction was subjected to RP-HPLC using Hi-Pour 214 Tp (by ...... syndromes with a combination therapy using lenalidomide and azacitidine.
Methods and devices for identifying biomarkers of treatment ...
Filed: January 1st, 1970 [Granted]
Patent Number: CA2631236A1
5. The method of claim 1, wherein said at least one gene is selected from the group ...... NOTE : Pour les tomes additionels, veuillez contacter le Bureau canadien ...... Asperlin, Azacitidine, Azetepa, Azotomycin, Batimastat, Benzodepa , ...... planar substrate, as is described, inter alia, in Brenner et al., Proc.
Preparation and compositions of highly bioavailable zerovalent ...
Preparation and compositions of highly bioavailable zerovalent ...
Filed: January 1st, 1970 [Granted]
Patent Number: US8771755
Pour, at once, 600 ml of Na2S2O5 solution into the auxiliary reaction vessel, which contains .... A detailed analysis of sulfitolysis is described in Koh et al., ..... cytarabine, azacitidine), plant alkaloids (e.g., vinblastine, etoposide, ...